Labcyte Acoustic Technology Going to Work for Cystic Fibrosis
WEDNESDAY, SEPTEMBER 21, 2016
State-of-the-art Echo Liquid Handling and Access Automation Workstation have been installed in the Cystic Fibrosis Foundation’s new 20,400 square foot research facility in Lexington, Mass, reports the Boston Business Journal. The lab’s 23 scientists are committed to speeding up the development of treatments for the disease, testing drugs using real CF cells. They are especially interested in finding treatments for the rarer gene mutations, since there is a lack of investment in this area at drug companies.
The new, larger lab allows for new equipment used in gene editing and stem cell therapies, as well, "We want to get in as early as possible to these technologies so when other people or companies move those technologies forward, we are ready for the CF-specific use,” said the Martin Mense, VP for Drug Discovery at the Cystic Fibrosis Foundation Therapeutics Research Laboratory.